Edmonds Duncan Registered Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Edmonds Duncan Registered Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,649	Closed	-$212K	–	134
2023 Q3	$212K	Hold	3,649	–	–	0.06%	124
2023 Q2	$233K	Hold	3,649	–	–	0.07%	120
2023 Q1	$253K	Hold	3,649	–	–	0.08%	112
2022 Q4	$263K	Hold	3,649	–	–	0.09%	104
2022 Q3	$259K	Hold	3,649	–	–	0.09%	94
2022 Q2	$281K	Hold	3,649	–	–	0.1%	92
2022 Q1	$266K	Hold	3,649	–	–	0.08%	116
2021 Q4	$236K	Hold	3,649	–	–	0.06%	122
2021 Q3	$216K	Hold	3,649	–	–	0.07%	130
2021 Q2	$244K	Hold	3,649	–	–	0.08%	118
2021 Q1	$230K	Sell	3,649 -1,200	-25%	-$74.7K	0.08%	117
2020 Q4	$296K	Sell	4,849 -1,000	-17%	-$61.5K	0.1%	101
2020 Q3	$353K	Hold	5,849	–	–	0.15%	82
2020 Q2	$344K	Hold	5,849	–	–	0.15%	84
2020 Q1	$326K	Hold	5,849	–	–	0.17%	82
2019 Q4	$375K	Buy	5,849 +300	+5%	+$17.2K	0.15%	81
2019 Q3	$281K	Hold	5,549	–	–	0.12%	91
2019 Q2	$256K	Buy	5,549 +200	+4%	+$9.32K	0.11%	100
2019 Q1	$255K	Hold	5,349	–	–	0.11%	102
2018 Q4	$278K	Hold	5,349	–	–	0.13%	91
2018 Q3	$332K	Hold	5,349	–	–	0.14%	87
2018 Q2	$296K	Hold	5,349	–	–	0.13%	92
2018 Q1	$338K	Hold	5,349	–	–	0.15%	82
2017 Q4	$327K	Hold	5,349	–	–	0.15%	84
2017 Q3	$335K	Hold	5,349	–	–	0.16%	83
2017 Q2	$298K	Hold	5,349	–	–	0.17%	78
2017 Q1	$288K	Sell	5,349 -438	-8%	-$24K	0.15%	77
2016 Q4	$338K	Hold	5,787	–	–	0.2%	73
2016 Q3	$286K	Buy	5,787 +38	+0.7%	+$2.44K	0.17%	88
2016 Q2	$337K	Sell	5,749 -100	-2%	-$7.07K	0.2%	76
2016 Q1	$374K	Buy	5,849 +40	+0.7%	+$2.52K	0.25%	69
2015 Q4	$400K	Buy	+5,809	New	+$384K	0.27%	64

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Edmonds Duncan Registered Investment Advisors's BMY Position: Q4 2023 in Review

Edmonds Duncan Registered Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,649 shares — an estimated $212K sold.

Edmonds Duncan Registered Investment Advisors first reported a position in BMY in Q4 2015 and held it in 32 quarters. The position peaked at $400K in Q4 2015. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Edmonds Duncan Registered Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Edmonds Duncan Registered Investment Advisors sold 3,649 Bristol-Myers Squibb shares in Q4 2023, an estimated $212K.
Edmonds Duncan Registered Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 32 quarters.
Edmonds Duncan Registered Investment Advisors's Bristol-Myers Squibb position peaked at $400K in Q4 2015.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Edmonds Duncan Registered Investment Advisors's 13F filing for Q4 2023, filed 11 Jan 2024.